Literature DB >> 21087805

Obliterative portal venopathy: portal hypertension is not always present at diagnosis.

Dominique Cazals-Hatem1, Sophie Hillaire, Marika Rudler, Aurélie Plessier, Valerie Paradis, Bertrand Condat, Claire Francoz, Marie-Hélène Denninger, François Durand, Pierre Bedossa, Dominique C Valla.   

Abstract

BACKGROUND & AIMS: Previous studies on obliterative portal venopathy (OPV) have been biased due to the selection of patients with non-cirrhotic portal hypertension. The aim of this study was to clarify the characteristics of OVP diagnosed by liver biopsy.
METHODS: Fifty-nine consecutive patients with OPV were retrospectively selected on strict histological criteria. Clinical, laboratory, portal vein patency, and associated disorders potentially involving vascular alterations were analyzed. The occurrence of complications was recorded during follow-up.
RESULTS: Mean age at diagnosis was 38.5±15 years old. Initial presentation was portal hypertension (64% of patients) and/or extrahepatic portal vein thrombosis (EHPVT) (22%) or isolated abnormal laboratory tests (20%). Associated diseases found at diagnosis were: prothrombotic disorders (30% of patients) and immune-mediated disorders (17%); 53% of patients had no causal factor (idiopathic OPV). During follow-up (median 8.6 years, range 1-23 years), features of portal hypertension worsened in 46% of patients; EHPVT and portal hypertension were finally found in 44% and 88% of patients. Anti-coagulation and beta-blockers were administered in 47% and 59% of patients, respectively. Severe complications (liver transplantation and/or death) occurred in 11 (19%) patients, 8 had idiopathic OPV. Patients with prothrombotic disorders received earlier anticoagulation therapy; all survived without transplantation.
CONCLUSIONS: A confident diagnosis of OPV can be done by biopsy and is conceivable in patients under 40 years without clinically significant portal hypertension. Poor outcome was noted in 19% of patients, most of them affected with idiopathic OPV. Patients with prothrombotic disorders received early anticoagulation and appeared to have a better outcome despite a high proportion of EHPVT. Copyright Â
© 2010 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 21087805     DOI: 10.1016/j.jhep.2010.07.038

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  31 in total

1.  Spectrum of histopathological changes in patients with non-cirrhotic portal fibrosis.

Authors:  Abhijit Chougule; Archana Rastogi; Rakhi Maiwall; Chhagan Bihari; Vikrant Sood; Shiv Kumar Sarin
Journal:  Hepatol Int       Date:  2018-04-12       Impact factor: 6.047

2.  Hepatobiliary quiz-12 (2014).

Authors:  Swastik Agrawal; Radha K Dhiman
Journal:  J Clin Exp Hepatol       Date:  2014-12

3.  Hepatobiliary quiz 11 (2014).

Authors:  Swastik Agrawal; Radha K Dhiman
Journal:  J Clin Exp Hepatol       Date:  2014-09

4.  Idiopathic Noncirrhotic Portal Hypertension.

Authors:  Harry L A Janssen
Journal:  Gastroenterol Hepatol (N Y)       Date:  2019-07

Review 5.  Idiopathic Non-Cirrhotic Intrahepatic Portal Hypertension (NCIPH)-Newer Insights into Pathogenesis and Emerging Newer Treatment Options.

Authors:  Ashish Goel; Joshua E Elias; Chundamannil E Eapen; Banumathi Ramakrishna; Elwyn Elias
Journal:  J Clin Exp Hepatol       Date:  2014-07-28

Review 6.  The current clinical aspects of idiopathic portal hypertension.

Authors:  Tomohiro Tanaka; Yasuhiko Sugawara; Norihiro Kokudo
Journal:  Intractable Rare Dis Res       Date:  2013-08

7.  Successful treatment of noncirrhotic portal hypertension with eculizumab in paroxysmal nocturnal hemoglobinuria: A case report.

Authors:  Alexandra Alexopoulou; Iliana Mani; Dina G Tiniakos; Flora Kontopidou; Ioanna Tsironi; Marina Noutsou; Helen Pantelidaki; Spyros P Dourakis
Journal:  World J Hepatol       Date:  2019-05-27

Review 8.  Vascular liver diseases on the clinical side: definitions and diagnosis, new concepts.

Authors:  Dominique-Charles Valla; Dominique Cazals-Hatem
Journal:  Virchows Arch       Date:  2018-03-24       Impact factor: 4.064

9.  Vascular liver lesions: contemporary views on long-recognized entities.

Authors:  Christine Sempoux; Paulette Bioulac-Sage
Journal:  Virchows Arch       Date:  2018-03-14       Impact factor: 4.064

10.  Abdominal infection reveals a rare disease.

Authors:  Clara Benedetta Conti; Mirella Fraquelli; Dario Conte
Journal:  Intern Emerg Med       Date:  2017-08-16       Impact factor: 3.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.